These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3851698)

  • 1. Modulation of natural killer activity by thymosin alpha 1 and interferon.
    Favalli C; Jezzi T; Mastino A; Rinaldi-Garaci C; Riccardi C; Garaci E
    Cancer Immunol Immunother; 1985; 20(3):189-92. PubMed ID: 3851698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.
    Favalli C; Mastino A; Jezzi T; Grelli S; Goldstein AL; Garaci E
    Int J Immunopharmacol; 1989; 11(5):443-50. PubMed ID: 2807622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.
    Garaci E; Mastino A; Pica F; Favalli C
    Cancer Immunol Immunother; 1990; 32(3):154-60. PubMed ID: 2126987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
    Pica F; Mastino A; Grelli S; Jezzi T; Favalli C
    J Chemother; 1989 Jul; 1(4 Suppl):1167-9. PubMed ID: 16312818
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of in vivo administration of prostaglandins and interferon on natural killer activity and on B-16 melanoma growth in mice.
    Garaci E; Mastino A; Jezzi T; Riccardi C; Favalli C
    Cell Immunol; 1987 Apr; 106(1):43-52. PubMed ID: 3568147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between thymic hormones and other immunomodulatory agents.
    Mastino A; Favalli C; Grelli S; Garaci E
    Ann Ist Super Sanita; 1991; 27(1):51-6. PubMed ID: 1958028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
    Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
    Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration.
    Di Francesco P; Pica F; Marini S; Favalli C; Garaci E
    Int J Immunopharmacol; 1992 Jan; 14(1):1-9. PubMed ID: 1582729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
    Umeda Y; Sakamoto A; Nakamura J; Ishitsuka H; Yagi Y
    Cancer Immunol Immunother; 1983; 15(2):78-83. PubMed ID: 6553515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced immune response and antitumor immunity with combinations of biological response modifiers.
    Garaci E; Mastino A; Favalli C
    Bull N Y Acad Med; 1989 Jan; 65(1):111-9. PubMed ID: 2481523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of mouse resistance to Candida albicans infection by thymosin alpha 1.
    Bistoni F; Marconi P; Frati L; Bonmassar E; Garaci E
    Infect Immun; 1982 May; 36(2):609-14. PubMed ID: 7085074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of natural killer cell activity in mice by treatment with a thymic factor.
    Bistoni F; Baccarini M; Puccetti P; Marconi P; Garaci E
    Cancer Immunol Immunother; 1984; 17(1):51-5. PubMed ID: 6563944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
    Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
    Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of immunocyte functions by thymosin alpha1 in cyclophosphamide-induced immunodeficient mice.
    Ohmori H; Kamo M; Yamakoshi K; Nitta MH; Hikida M; Kanayama N
    Immunopharmacol Immunotoxicol; 2001 Feb; 23(1):75-82. PubMed ID: 11322651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of thymosin alpha 1 on cellular immune function in elderly patients with malignant tumor].
    Yang YM; Lu XY; Huang WD; Shen MY
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):339-41. PubMed ID: 12970939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
    Garaci E; Pica F; Mastino A; Palamara AT; Belardelli F; Favalli C
    J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):7-17. PubMed ID: 8435433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.
    Serrate SA; Schulof RS; Leondaridis L; Goldstein AL; Sztein MB
    J Immunol; 1987 Oct; 139(7):2338-43. PubMed ID: 3116079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine enhances interferon induced augmentation of NK cell activity and suppresses interferon production.
    Hirai N; Hill NO; Motoo Y; Osther K
    Acta Pathol Microbiol Immunol Scand C; 1985 Aug; 93(4):153-9. PubMed ID: 4050442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective activity of thymosin alpha 1 against tumor progression in immunosuppressed mice.
    Ishitsuka H; Umeda Y; Sakamoto A; Yagi Y
    Adv Exp Med Biol; 1983; 166():89-100. PubMed ID: 6650286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.